Trademarkia Logo

Canada

C$
SYNCROVAX
ADVERTISED

on 5 Feb 2025

Last Applicant/ Owned by

Syncromune, Inc.

P.O. Box 39454Fort Lauderdale FL 33339

US

Serial Number

2211250 filed on 20th Jul 2022

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

SYNCROVAX

Trademark usage description

pharmaceutical products for the treatment of cancer. pharmaceutical drug development services; scientific development of precision therapies for canc Read More

Classification Information


Class [005]
Pharmaceutical products for the treatment of cancer.


Classification kind code

11

Class [042]
Pharmaceutical drug development services; scientific development of precision therapies for cancers; product development in the field of drug delivery technologies.


Classification kind code

11

Mark Details


Serial Number

2211250

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 23rd May 2024
Agent Changed
Submitted for opposition 22
on 8th Jan 2024
Search Recorded
Submitted for opposition 20
on 8th Jan 2024
Examiner's First Report
Submitted for opposition 223
on 8th Jan 2024
Total Provisional Refusal
Submitted for opposition 256
on 24th Jul 2023
Notification of Possible Opposition Sent
Submitted for opposition 257
on 22nd Sept 2022
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 21st Sept 2022
Formalized
Submitted for opposition 1
on 21st Sept 2022
Created
Submitted for opposition 228
on 20th Jul 2022
International Registration
Submitted for opposition 30
on 20th Jul 2022
Filed